Track market-moving stories before they get noisy

[url="]Keysight Technologies, Inc.[/url] (NYSE: KEYS) today announced Keysight Eggplant Find by Description, which allows automation engineers to locate interf

HomeIndustriesAerospace/DefenseMorgan Stanley says the bull case for the rocket-launch stock is now much rosier as the company diversifies its businessUpdated July 8, 2026, 12:03 p.m. ET

Rocket Lab is following a well-worn path by SpaceX, which has analysts cheering on its future as an “emerging space platform.”

Morgan Stanley analysts on Wednesday raised their bull-case target price for the company’s stock to $293 from $185, noting that Rocket Lab RKLB is increasingly resembling a miniature SpaceX SPCX. That implies upside of 259% from current trading levels on Wednesday.

Silver prices collapse nearly 2.50% on Wednesday as risk aversion drives traders towards buying the US Dollar, to the detriment of precious metals. At the time of writing, the XAG/USD trades at $58.41 after waking at around $61.03.

XAG/USD Price Forecast: Technical outlookSilver is still downward biased, extending the series of successive lower highs and lower lows, besides its trading below the 200-day Simple Moving Average (SMA) at $70.19.

The Relative Strength Index (RSI) is bearishly biased as the index approaches oversold territory.

For a bearish continuation, if XAG/USD dives below the June 30 daily low of $56.61, this clears the path towards $55.79, the June 26 swing low. Below this level, the next area of interest is the November 13, 2025, daily low-turned-support at $54.39, ahead of the $50.00 figure.

On the upside, buyers must clear the latest cycle high of $63.28, the July 6 high, followed by the June 22 daily peak at $67.17, ahead of the $70.00 figure.

XAG/USD Price Chart - Daily

Silver daily chart Silver FAQs Silver is a precious metal highly traded among investors. It has been historically used as a store of value and a medium of exchange. Although less popular than Gold, traders may turn to Silver to diversify their investment portfolio, for its intrinsic value or as a potential hedge during high-inflation periods. Investors can buy physical Silver, in coins or in bars, or trade it through vehicles such as Exchange Traded Funds, which track its price on international markets.

Silver prices can move due to a wide range of factors. Geopolitical instability or fears of a deep recession can make Silver price escalate due to its safe-haven status, although to a lesser extent than Gold's. As a yieldless asset, Silver tends to rise with lower interest rates. Its moves also depend on how the US Dollar (USD) behaves as the asset is priced in dollars (XAG/USD). A strong Dollar tends to keep the price of Silver at bay, whereas a weaker Dollar is likely to propel prices up. Other factors such as investment demand, mining supply – Silver is much more abundant than Gold – and recycling rates can also affect prices.

Silver is widely used in industry, particularly in sectors such as electronics or solar energy, as it has one of the highest electric conductivity of all metals – more than Copper and Gold. A surge in demand can increase prices, while a decline tends to lower them. Dynamics in the US, Chinese and Indian economies can also contribute to price swings: for the US and particularly China, their big industrial sectors use Silver in various processes; in India, consumers’ demand for the precious metal for jewellery also plays a key role in setting prices.

Silver prices tend to follow Gold's moves. When Gold prices rise, Silver typically follows suit, as their status as safe-haven assets is similar. The Gold/Silver ratio, which shows the number of ounces of Silver needed to equal the value of one ounce of Gold, may help to determine the relative valuation between both metals. Some investors may consider a high ratio as an indicator that Silver is undervalued, or Gold is overvalued. On the contrary, a low ratio might suggest that Gold is undervalued relative to Silver.

Neurocrine Biosciences (NBIX - Free Report) could be a solid choice for investors given its recent upgrade to a Zacks Rank #1 (Strong Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices.

A company's changing earnings picture is at the core of the Zacks rating. The system tracks the Zacks Consensus Estimate -- the consensus measure of EPS estimates from the sell-side analysts covering the stock -- for the current and following years.

The power of a changing earnings picture in determining near-term stock price movements makes the Zacks rating system highly useful for individual investors, since it can be difficult to make decisions based on rating upgrades by Wall Street analysts. These are mostly driven by subjective factors that are hard to see and measure in real time.

As such, the Zacks rating upgrade for Neurocrine is essentially a positive comment on its earnings outlook that could have a favorable impact on its stock price.

Most Powerful Force Impacting Stock PricesThe change in a company's future earnings potential, as reflected in earnings estimate revisions, and the near-term price movement of its stock are proven to be strongly correlated. That's partly because of the influence of institutional investors that use earnings and earnings estimates for calculating the fair value of a company's shares. An increase or decrease in earnings estimates in their valuation models simply results in higher or lower fair value for a stock, and institutional investors typically buy or sell it. Their bulk investment action then leads to price movement for the stock.

For Neurocrine, rising earnings estimates and the consequent rating upgrade fundamentally mean an improvement in the company's underlying business. And investors' appreciation of this improving business trend should push the stock higher.

Harnessing the Power of Earnings Estimate RevisionsAs empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock movements, tracking such revisions for making an investment decision could be truly rewarding. Here is where the tried-and-tested Zacks Rank stock-rating system plays an important role, as it effectively harnesses the power of earnings estimate revisions.

The Zacks Rank stock-rating system, which uses four factors related to earnings estimates to classify stocks into five groups, ranging from Zacks Rank #1 (Strong Buy) to Zacks Rank #5 (Strong Sell), has an impressive externally-audited track record, with Zacks Rank #1 stocks generating an average annual return of +25% since 1988. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here >>>> .

Earnings Estimate Revisions for NeurocrineFor the fiscal year ending December 2026, this biopharmaceutical company is expected to earn $9.47 per share, which is unchanged compared with the year-ago reported number.

Analysts have been steadily raising their estimates for Neurocrine. Over the past three months, the Zacks Consensus Estimate for the company has increased 20.7%.

Bottom LineUnlike the overly optimistic Wall Street analysts whose rating systems tend to be weighted toward favorable recommendations, the Zacks rating system maintains an equal proportion of "buy" and "sell" ratings for its entire universe of more than 4,000 stocks at any point in time. Irrespective of market conditions, only the top 5% of the Zacks-covered stocks get a "Strong Buy" rating and the next 15% get a "Buy" rating. So, the placement of a stock in the top 20% of the Zacks-covered stocks indicates its superior earnings estimate revision feature, making it a solid candidate for producing market-beating returns in the near term.

You can learn more about the Zacks Rank here >>>

The upgrade of Neurocrine to a Zacks Rank #1 positions it in the top 5% of the Zacks-covered stocks in terms of estimate revisions, implying that the stock might move higher in the near term.

Momentum investing is all about the idea of following a stock's recent trend, which can be in either direction. In the "long context," investors will essentially be "buying high, but hoping to sell even higher." And for investors following this methodology, taking advantage of trends in a stock's price is key; once a stock establishes a course, it is more than likely to continue moving in that direction. The goal is that once a stock heads down a fixed path, it will lead to timely and profitable trades.

Even though momentum is a popular stock characteristic, it can be tough to define. Debate surrounding which are the best and worst metrics to focus on is lengthy, but the Zacks Momentum Style Score, part of the Zacks Style Scores, helps address this issue for us.

Below, we take a look at Zions (ZION - Free Report) , which currently has a Momentum Style Score of A. We also discuss some of the main drivers of the Momentum Style Score, like price change and earnings estimate revisions.

It's also important to note that Style Scores work as a complement to the Zacks Rank, our stock rating system that has an impressive track record of outperformance. Zions currently has a Zacks Rank of #2 (Buy). Our research shows that stocks rated Zacks Rank #1 (Strong Buy) and #2 (Buy) and Style Scores of "A or B" outperform the market over the following one-month period.

You can see the current list of Zacks #1 Rank Stocks here >>>

Set to Beat the Market?Let's discuss some of the components of the Momentum Style Score for ZION that show why this financial holding company shows promise as a solid momentum pick.

A good momentum benchmark for a stock is to look at its short-term price activity, as this can reflect both current interest and if buyers or sellers currently have the upper hand. It's also helpful to compare a security to its industry; this can show investors the best companies in a particular area.

For ZION, shares are up 0.3% over the past week while the Zacks Banks - West industry is up 0.53% over the same time period. Shares are looking quite well from a longer time frame too, as the monthly price change of 9.04% compares favorably with the industry's 4.58% performance as well.

While any stock can see a spike in price, it takes a real winner to consistently outperform the market. Shares of Zions have increased 14.59% over the past quarter, and have gained 27.25% in the last year. In comparison, the S&P 500 has only moved 13.69% and 21.71%, respectively.

Investors should also pay attention to ZION's average 20-day trading volume. Volume is a useful item in many ways, and the 20-day average establishes a good price-to-volume baseline; a rising stock with above average volume is generally a bullish sign, whereas a declining stock on above average volume is typically bearish. ZION is currently averaging 1,639,344 shares for the last 20 days.

Earnings OutlookThe Zacks Momentum Style Score encompasses many things, including estimate revisions and a stock's price movement. Investors should note that earnings estimates are also significant to the Zacks Rank, and a nice path here can be promising. We have recently been noticing this with ZION.

Over the past two months, 8 earnings estimates moved higher compared to none lower for the full year. These revisions helped boost ZION's consensus estimate, increasing from $6.41 to $6.49 in the past 60 days. Looking at the next fiscal year, 7 estimates have moved upwards while there have been no downward revisions in the same time period.

Bottom LineTaking into account all of these elements, it should come as no surprise that ZION is a #2 (Buy) stock with a Momentum Score of A. If you've been searching for a fresh pick that's set to rise in the near-term, make sure to keep Zions on your short list.

Zebra Technologies Corporation ZBRA is witnessing growth across the healthcare, manufacturing and retail & ecommerce end markets. Higher sales of mobile computing solutions are driving the company's Connected Frontline segment.

, /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to Hub Group, Inc. ("Hub Group" or the "Company") (NASDAQ: HUBG) have opportunity to lead the securities fraud class action lawsuit.

IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN HUB GROUP, INC. (HUBG), CLICK HERE BEFORE AUGUST 28, 2026 (THE LEAD PLAINTIFF DEADLINE) TO PARTICIPATE IN THE ONGOING SECURITIES FRAUD LAWSUIT.

 What Is The Lawsuit About?
The complaint filed alleges that, between April 28, 2023 and May 11, 2026, Defendants failed to disclose to investors that: (1) the Company's financial statements prepared for the periods from Q1 2023 to Q4 2024 contained material misstatements caused by the premature and incorrect recognition of certain transactions; (2) the Company's financial statements prepared for the periods from Q1 2025 to Q3 2025 contained material misstatements caused by the understatement of purchased transportation costs and accounts payable; and (3) as a result, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis at all relevant times.

Contact Us To Participate or Learn More: 
If you wish to learn more about this action, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact us.
The Law Offices of Frank R. Cruz, 
Email us at: [email protected]
Call us at: 310-914-5007
Visit our website at: www.frankcruzlaw.com
Follow us for updates on Twitter: twitter.com/FRC_LAW.

If you inquire by email, please include your mailing address, telephone number, and number of shares purchased.

To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action.  

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

SOURCE The Law Offices of Frank R. Cruz, Los Angeles

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay Wolke & Rotter LLP reminds investors of the upcoming August 31, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Insulet Corporation (“Insulet” or the “Company”) (NASDAQ: PODD) securities between February 21, 2025 and May 26, 2026, inclusive (the “Class Period”).

IF YOU SUFFERED A LOSS ON YOUR INSULET INVESTMENTS, CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS UNDER THE FEDERAL SECURITIES LAWS.

What Happened?

On March 12, 2026, Insulet disclosed that it had “initiated a voluntary Medical Device Correction for specific lots of Omnipod® 5 Pods after identifying a manufacturing issue through its ongoing product monitoring.”

On this news, Insulet’s stock price fell $16.23, or 6.9%, to close at $219.84 per share on March 13, 2026, thereby injuring investors.

Then, on May 26, 2026, Insulet announced the initiation of another “voluntary Medical Device Correction” for “specific lots of Omnipod® 5, Omnipod Dash®, and Omnipod® Insulin Management System (Omnipod Eros) Pods due to a manufacturing issue, identified through ongoing product monitoring, that could result in insulin under-delivery.”

On this news, Insulet’s stock price fell $7.79, or 5.1%, to close at $146.01 per share on May 27, 2026, thereby injuring investors further.

What Is The Lawsuit About?

The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, Defendants failed to disclose to investors that: (1) Insulet’s manufacturing controls and procedures were defective; (2) the foregoing created a foreseeable heightened risk that one or more Insulet products would be found to be in violation of applicable safety regulations and/or pose a risk of injury; and (3) as a result, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis at all relevant times.

If you purchased or otherwise acquired Insulet securities during the Class Period, you may move the Court no later than August 31, 2026 to request appointment as lead plaintiff in this putative class action lawsuit.

Contact Us To Participate or Learn More:

If you wish to learn more about this action, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact us:

Charles Linehan, Esq.,
Glancy Prongay Wolke & Rotter LLP,
1925 Century Park East, Suite 2100,
Los Angeles California 90067
Email: [email protected]
Telephone: 310-201-9150,
Toll-Free: 888-773-9224
Visit our website at www.glancylaw.com.
Follow us for updates on LinkedIn, Twitter, or Facebook.

If you inquire by email, please include your mailing address, telephone number and number of shares purchased.

To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Insulet To Contact Him Directly To Discuss Their Options

If you purchased or acquired securities in Insulet between February 21, 2025 and May 26, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).

[You may also click here for additional information]

New York, New York--(Newsfile Corp. - July 8, 2026) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Insulet Corporation ("Insulet" or the "Company") (NASDAQ: PODD) and reminds investors of the August 31, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of dollars for investors since its founding in 1995. See www.faruqilaw.com.

As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that: (i) Insulet's manufacturing controls and procedures were defective; (ii) the foregoing created a foreseeable heightened risk that one or more Insulet products would be found to be in violation of applicable safety regulations and/or pose a risk of injury; and (iii) as a result, Defendants' public statements were materially false and misleading at all relevant times.

The truth began to emerge on March 12, 2026, when Insulet disclosed that it had "initiated a voluntary Medical Device Correction for specific lots of Omnipod® 5 Pods after identifying a manufacturing issue through its ongoing product monitoring."

On this news, Insulet's stock price fell $16.23 per share, or 6.88%, to close at $219.84 per share on March 13, 2026.

Then, on May 26, 2026, Insulet disclosed the "initat[ion]" of another "voluntary Medical Device Correction", this time "for specific lots of Omnipod® 5, Omnipod Dash®, and Omnipod® Insulin Management System (Omnipod Eros) Pods due to a manufacturing issue, identified through ongoing product monitoring, that could result in insulin under-delivery."

On this news, Insulet's stock price fell $7.79 per share, or 5.07%, to close at $146.01 per share on May 27, 2026.

The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class who is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not.

Faruqi & Faruqi, LLP also encourages anyone with information regarding Insulet's conduct to contact the firm, including whistleblowers, former employees, shareholders and others.

To learn more about the Insulet class action, go to www.faruqilaw.com/PODD or call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).

Follow us for updates on LinkedIn, on X, or on Facebook.

Frequently Asked Questions (FAQ) for Investors Regarding the Insulet Securities Class Action Lawsuit:

What is the Insulet securities fraud lawsuit about?

Faruqi & Faruqi, LLP has filed a securities class action lawsuit against Insulet Corporation (NASDAQ: PODD) on behalf of investors who purchased Insulet securities during the Class Period. The lawsuit alleges that Insulet's manufacturing controls and procedures were defective, and that this deficiency allegedly created a foreseeable, heightened risk that one or more Insulet products would be found to violate applicable safety regulations or pose a risk of injury to patients. The complaint further alleges that, as a result, Insulet's public statements during the Class Period were materially false and misleading. The alleged truth began to emerge through two separate voluntary Medical Device Corrections disclosed by Insulet in March and May 2026, each involving manufacturing issues with specific lots of Omnipod® products, which were followed by significant declines in Insulet's stock price.

Who may be eligible to participate in the lawsuit?

Investors who purchased or otherwise acquired Insulet Corporation (NASDAQ: PODD) securities on the NASDAQ exchange between February 21, 2025 and May 26, 2026, inclusive, may be eligible to participate in this lawsuit. Eligibility to participate is not limited to those who seek appointment as lead plaintiff; any investor who purchased during the Class Period may be entitled to share in any recovery that may be obtained. Investors are encouraged to review their trading records to determine whether their purchases fall within the defined Class Period. Additional eligibility considerations may apply, and investors are advised to consult with counsel to evaluate their specific circumstances.

What is a lead plaintiff, and how can I seek appointment?

A lead plaintiff is a court-appointed representative party who acts on behalf of all class members in directing the litigation, including making key decisions regarding litigation strategy, selection of counsel, and settlement negotiations. Under the Private Securities Litigation Reform Act, any member of the proposed class may move the court for appointment as lead plaintiff, and the court will generally appoint the movant with the largest financial interest in the relief sought who otherwise satisfies applicable legal requirements. The deadline to file a motion seeking appointment as lead plaintiff in this action is August 31, 2026. Importantly, investors are not required to seek appointment as lead plaintiff in order to participate in the class or share in any recovery that may result from the litigation.

What should investors do if they purchased Insulet stock during the Class Period?

Investors who purchased Insulet Corporation (NASDAQ: PODD) securities between February 21, 2025 and May 26, 2026 are encouraged to review their brokerage and trading records to confirm whether their purchases fall within the Class Period. Investors should take steps to preserve all relevant documentation, including trade confirmations, account statements, and any communications related to their Insulet holdings. Given that the lead plaintiff motion deadline is August 31, 2026, investors who wish to be considered for appointment as lead plaintiff should act promptly to avoid missing that deadline. Investors interested in learning more about the lawsuit or their potential legal rights and options may contact Faruqi & Faruqi, LLP to discuss their circumstances prior to the deadline, though retaining counsel or seeking lead plaintiff status is not required to participate in any potential class recovery.

Why should investors contact Faruqi & Faruqi, LLP?

Faruqi & Faruqi, LLP has represented investors in securities litigation for decades and has recovered hundreds of millions of dollars for shareholders. Investors who purchased Insulet securities during the Class Period may contact the firm to discuss their legal rights, potential claims, and the lead plaintiff process at no cost or obligation.

Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/304428

Source: Faruqi & Faruqi LLP

Ready to Announce with Confidence? Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.

Contact Us

Key Takeaways Unum US is UNM's largest segment, generating the majority of premium revenue, earnings and cash flow. Strong employer relationships, recurring premiums, and a diversified benefits portfolio aid profitability. Rising demand for workplace benefits, disciplined pricing and technology investments boost long-term growth. Unum Group's (UNM - Free Report) Unum US segment is its largest and most important operating business, serving as the primary driver of the company's premium revenue, earnings and cash flow. The segment provides a broad portfolio of employer-sponsored financial protection products, including group long-term and short-term disability insurance, group life and accidental death & dismemberment, voluntary benefits, individual disability, and dental and vision insurance. Products are distributed primarily through employers, independent brokers and consultants, with a strategic focus on both small and mid-sized businesses and large employer groups.

Unum US benefits from recurring premium income, strong customer retention and long-standing employer relationships, making it the cornerstone of Unum Group's financial performance. The business is also a market leader in disability insurance, leveraging underwriting expertise, claims management capabilities and integrated employee benefit solutions to generate consistent profitability. Its diversified product portfolio enables cross-selling opportunities while reducing dependence on any single product line, supporting resilient earnings across economic cycles.

The segment remains a key growth engine as employers continue to expand workplace benefits to attract and retain employees. Rising demand for income protection, voluntary benefits, leave management services, and comprehensive employee benefit solutions positions Unum US to benefit from favorable long-term workplace trends. Combined with disciplined pricing, technology investments and efficient claims administration, Unum US continues to strengthen Unum Group's competitive position and supports sustainable earnings and capital generation.

Unum US serves as Unum Group's primary earnings engine, contributing the majority of premium revenue while generating stable underwriting profits, recurring cash flows and investment income.

What About Its Peers?Selective Insurance Group, Inc. (SIGI - Free Report) has a strong presence in the standard commercial lines market, focusing primarily on small and middle-market businesses. Selective Insurance continues to expand its Standard Commercial Lines footprint with the goal of a near national presence, while maintaining an agent-driven distribution model. Standard Commercial Lines is the core revenue driver for Selective Insurance Group, making it the company's primary earnings engine. It generates the majority of the company's premium revenues and serves as the foundation of the long-term growth strategy.

Kinsale Capital Group, Inc. (KNSL - Free Report) focuses exclusively on the excess and surplus lines (E&S) market in the United States. Kinsale Capital's Excess and Surplus Lines Insurance segment is the company's sole operating business and core growth engine. Its specialization in hard-to-place commercial risks, combined with disciplined underwriting and technology-driven efficiency, has enabled the company to generate industry-leading underwriting profitability consistently. The E&S Lines Insurance segment is the foundation of Kinsale Capital's business model. It aids the company by providing pricing flexibility, higher underwriting margins, premium growth opportunities, operational efficiency and a defensible competitive niche.

UNM’s Price PerformanceShares of UNM have gained 15.1% in the year-to-date period, outperforming the industry.

Image Source: Zacks Investment Research

UNM’s UndervaluationThe stock is undervalued compared with its industry. Its forward price-to-book value of 1.31X is lower than the industry average of 1.78X. It carries a Value Score of B.

Image Source: Zacks Investment Research

Estimate Movement for UNMThe Zacks Consensus Estimate for UNM’s second-quarter 2026 EPS has moved down 0.4% in the past 60 days. The same for the full-year 2026 and 2027 EPS has moved up 0.4% and moved down 0.6%, respectively, in the past 60 days.

Image Source: Zacks Investment Research

Grants support American Red Cross and Food Bank of Northwest Indiana as Indiana American Water employees volunteer to assist impacted communities 

, /PRNewswire/ -- The American Water Charitable Foundation, a philanthropic nonprofit organization established by American Water, has provided $30,000 in disaster relief support to assist Northwest Indiana communities recovering from late June severe storms and tornadoes. The support includes a $25,000 grant to the American Red Cross Northwest Chapter, Indiana Region and a $5,000 grant to the Food Bank of Northwest Indiana to help meet ongoing community needs.

"Right now, the need is great," said Dr. Sarah Moss, Executive Director of the Northwest Chapter of the American Red Cross Indiana Region. "The Red Cross has been on the ground in the community since the night the storms hit, providing shelter, meals, relief items, comfort and essential living needs to people who have been impacted. We are so appreciative of the American Water Charitable Foundation's support and partnership, and we know this contribution will be put to excellent use for people here in the community who need help."

The grants will help support organizations providing shelter, meals, relief supplies, food assistance and essential services to residents impacted by the storms. The American Water Charitable Foundation focuses on three pillars of giving: Water, People and Communities, and supports initiatives that improve communities served by American Water.

As of June 30, the Red Cross had provided more than 350 overnight shelter stays for 36 individuals, more than 2,600 meals and 3,316 relief items, impacting 800 homes in the community.

In addition to the charitable grants, Indiana American Water employees volunteered their time, equipment and expertise to support cleanup efforts in affected neighborhoods. Working with Lake County Emergency Management and other community partners, employees helped remove downed trees and limbs, clear debris and make roads passable for residents and emergency crews.

"A lot of people live and work in this community, and our employees were the first ones to step up and say we needed to do something," said Sam Mouratides, Superintendent of Operations for Northwest Indiana. "We are here to do everything we can to help get this area back together and get people back to normal life."

Many Indiana American Water team members live in the affected communities, have family in the area or saw the damage firsthand while continuing essential work to keep water and wastewater infrastructure operating through heavy rain and widespread power outages.

"We're here today to be good neighbors and good citizens before employees," said Jason Phelps, Mechanic Crew Chief for Indiana American Water. "We're proud to show up for our community, especially when people need it most, using the equipment and skills we have to make a difference for our neighbors.

The volunteer effort included nearly two dozen employees during one coordinated cleanup event, with additional teams supporting work throughout the week. Crews offered specialized equipment, including backhoes, dump trucks and pumps, to assist with cleanup and recovery needs, reflecting Indiana American Water's commitment to the communities where its employees live and work.

"Our employees care deeply about what they do, not only delivering clean, safe drinking water to our customers, but also helping out any way we can," said Justin Mount, Northwest Indiana Senior Operations Manager, Indiana American Water. "We live and work in the communities we serve, and this is a great way to put our resources to work helping the community."

Learn more about Indiana American Water's community impact at https://www.amwater.com/inaw/news-community/Community-Involvement/

About American Water 
American Water (NYSE: AWK) is the largest regulated water and wastewater utility company in the United States. With a history dating back to 1886 and celebrating 140 years in 2026, We Keep Life Flowing® by providing safe, clean, reliable and affordable drinking water and wastewater services to approximately 14 million people with regulated operations in 14 states and on 18 military installations. American Water's approximately 7,000 talented professionals leverage their significant expertise and the company's national size and scale to achieve excellent outcomes for the benefit of customers, employees, investors and other stakeholders. For more information, visit amwater.com and join American Water on LinkedIn, Facebook, X and Instagram. 
 

About American Water Charitable Foundation 
The American Water Charitable Foundation, a philanthropic non-profit organization established by American Water, focuses on three pillars of giving: Water, People, and Communities. Since 2012, the Foundation has invested over $25 million in funding through grants and matching gifts to support eligible organizations in communities served by American Water. The Foundation is funded by American Water shareholders and has no impact on customer rates. For more information, visit amwater.com/awcf. 

About Indiana American Water
Indiana American Water, a subsidiary of American Water, is the largest regulated water utility in the state, providing safe, clean, reliable, and affordable water and wastewater services to approximately 1.5 million people.

SOURCE American Water

New York, New York--(Newsfile Corp. - July 8, 2026) - Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against CommVault Systems, Inc. (NASDAQ: CVLT) and certain of its officers.

This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired CommVault securities between April 29, 2025 and January 26, 2026, both dates inclusive (the "Class Period"). Such investors are encouraged to join this case by visiting the firm's site: bgandg.com/CVLT.

CommVault Case Details

The Complaint alleges that, throughout the Class Period, Defendants made materially false and misleading statements and/or failed to disclose that:

Defendants provided investors with misleading guidance and projections regarding CommVault's anticipated annual recurring revenue ("ARR") growth for fiscal year 2026, including projections related to new net ARR growth; Defendants simultaneously disseminated overly positive statements while concealing material adverse facts concerning the true state of the Company's ARR growth environment; Defendants knew or recklessly disregarded that the Company's ARR growth guidance failed to properly account for critical variables, including the type of sales driving ARR performance; and as a result, Defendants' statements about the Company's business, operations, and prospects lacked a reasonable basis and were materially false and misleading at all relevant times.What's Next for CommVault Investors?

A class action lawsuit has already been filed. If you wish to review a copy of the Complaint, you can visit the firm's site: bgandg.com/CVLT, or you may contact Peretz Bronstein, Esq. or his Client Relations Manager, Nathan Miller, of Bronstein, Gewirtz & Grossman, LLC at 917-590-0911. If you suffered a loss in CommVault you have until July 17, 2026, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as lead plaintiff.

No Cost to CommVault Investors

We, Bronstein, Gewirtz & Grossman LLC, represent investors in class actions on a contingency fee basis. That means we will ask the court to reimburse us for out-of-pocket expenses and attorneys' fees, usually a percentage of the total recovery, only if we are successful.

Why Bronstein, Gewirtz & Grossman, LLC for CommVault Securities Class Action?

Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide. More at www.bgandg.com

"Our practice centers on restoring investor capital and ensuring corporate accountability, which serves to uphold the essential integrity of the marketplace," said Peretz Bronstein, Founding Partner of Bronstein, Gewirtz & Grossman, LLC.

Follow us for updates on LinkedIn, X, Facebook, or Instagram.

Attorney advertising.
Prior results do not guarantee similar outcomes.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/298057

Source: Bronstein, Gewirtz & Grossman, LLC

Ready to Announce with Confidence? Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.

Contact Us

LOS ANGELES, July 08, 2026 (GLOBE NEWSWIRE) -- Glancy Prongay Wolke & Rotter LLP reminds investors of the upcoming July 17, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Commvault Systems Inc. (“Commvault” or the “Company”) (NASDAQ: CVLT) securities between January 28, 2025 and January 26, 2026, inclusive (the “Class Period”).

IF YOU SUFFERED A LOSS ON YOUR COMMVAULT INVESTMENTS, CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS UNDER THE FEDERAL SECURITIES LAWS.

What Happened?
On January 27, 2026, Commvault published third quarter 2026 fiscal results, including annualized recurring revenue (“ARR”) of 22% and a total net new ARR was $39 million, falling short of the prior quarter’s guidance for $45 million of net new ARR for the quarter. Management revealed in the accompanying earnings call that the variation was due to product mix, including increased SaaS deals in the quarter.

On this news, Commvault’s stock price fell $40.23, or 31.1%, to close at $89.13 per share on January 27, 2026, thereby injuring investors.

What Is The Lawsuit About?
The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, Defendants failed to disclose to investors that: (1) Commvault knew or recklessly disregarded the impact that different types of sales would have on its ARR growth; (2) the variation in net ARR growth is strongly based on the type of sale Commvault is making, thus, the Company’s projected net new ARR should not have been determined without properly factoring in sale type; and (3) as a result, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis at all relevant times.

If you purchased or otherwise acquired Commvault securities during the Class Period, you may move the Court no later than July 17, 2026 to request appointment as lead plaintiff in this putative class action lawsuit.

Contact Us To Participate or Learn More:
If you wish to learn more about this action, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact us:
Charles Linehan, Esq.,
Glancy Prongay Wolke & Rotter LLP,
1925 Century Park East, Suite 2100,
Los Angeles California 90067
Email:  [email protected]
Telephone: 310-201-9150,
Toll-Free: 888-773-9224
Visit our website at www.glancylaw.com.
Follow us for updates on LinkedIn, Twitter, or Facebook.

If you inquire by email, please include your mailing address, telephone number and number of shares purchased.

To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contact Us:
Glancy Prongay Wolke & Rotter LLP,
1925 Century Park East, Suite 2100
Los Angeles, CA 90067
Charles Linehan
Email:  [email protected]
Telephone: 310-201-9150
Toll-Free: 888-773-9224
Visit our website at: www.glancylaw.com.

NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Crinetics Pharmaceuticals, Inc. (NasdaqGS: CRNX) to Vertex Pharmaceuticals Incorporated (NasdaqGS: VRTX). Under the terms of the proposed transaction, shareholders of Crinetics will receive $85.00 in cash for each share of Crinetics that they own. KSF is seeking to determine whether this consideratio.

Key Takeaways SAM is leveraging pricing, procurement savings and brewery optimization to support margins.Boston Beer is expanding Sun Cruiser, Truly Unruly and Sinless Vodka Cocktails to drive growth. SAM is investing in core brands, Beyond Beer innovation and targeted marketing to strengthen long-term growth. The Boston Beer Company, Inc. (SAM - Free Report) has been making strategic initiatives to aid growth. SAM’s consistent focus on pricing, product innovation and growth of non-beer categories, alongside brand development, bodes well. Boston Beer continues to benefit from strategic pricing actions, procurement savings, brewery optimization and revenue-management initiatives that help offset inflationary and tariff-related cost pressures.

Ongoing efficiency improvements across brewing operations, procurement, waste reduction and network optimization are enhancing operating leverage, while modest pricing and a favorable product mix are expected to further support margin expansion.

Product innovation remains a key pillar of Boston Beer’s growth strategy. The company is broadening its offerings with new flavors, pack sizes and premium products across its major brands. The strong momentum of Sun Cruiser, expansion of Truly Unruly, continued innovation in Twisted Tea and the wider rollout of Sinless Vodka Cocktails position the company to capture evolving consumer preferences and benefit from growth in the ready-to-drink beverage market.

Boston Beer is executing a strategy focused on strengthening its core brands, expanding the Beyond Beer portfolio and driving profitable growth. The company continues to invest in brand equity, introduce new product formats, expand Truly Unruly, support Samuel Adams through targeted marketing and capitalize on major events to increase brand visibility. These initiatives are expected to reinforce its long-term growth prospects.

Boston Beer is focused on the revival of its Samuel Adams and Angry Orchard brands, cost-saving initiatives and long-term innovation. The company believes that there is an opportunity for Hard Mountain Dew, within the expanded pack sizes and channels, with convenience stores. Such efforts are likely to bolster SAM’s profitability.

SAM’s Price Performance, Valuation and EstimatesShares of Boston Beer have lost 11.9% year to date compared with the industry’s growth of 8.9%.

Image Source: Zacks Investment Research

From a valuation standpoint, SAM trades at a forward price-to-earnings ratio of 17.32X compared with the industry’s average of 14.99X.

Image Source: Zacks Investment Research

The Zacks Consensus Estimate for SAM’s 2026 earnings per share (EPS) indicates a drop of 1.2% year over year while that of 2027 indicates year-over-year growth of 15.9%. The company’s EPS estimates for 2026 and 2027 have been stable in the past 30 days.

Boston Beer stock currently carries a Zacks Rank #3 (Hold).

Stocks to Consider in the Consumer Staples SpaceThe Chefs' Warehouse, Inc. (CHEF - Free Report) , which is a distributor of specialty food products in the United States, currently sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

The Zacks Consensus Estimate for Chefs' Warehouse's current financial-year sales indicates growth of 8.3% from the prior-year level. CHEF delivered a trailing four-quarter earnings surprise of 28.9%, on average.

Nomad Foods Limited (NOMD - Free Report) , which manufactures and distributes frozen foods, currently carries a Zacks Rank #2 (Buy).

The consensus estimate for Nomad Foods’ current financial-year sales is expected to rise 0.5% from the year-ago reported figure. NOMD delivered a trailing four-quarter earnings surprise of 8.6%, on average.

Medifast, Inc. (MED - Free Report) , which is a leading manufacturer and distributor of clinically-proven healthy living products and programs, currently carries a Zacks Rank of 2. MED delivered an average earnings surprise of 65.5% in the last reported quarter.

The Zacks Consensus Estimate for Medifast’s current financial-year sales indicates a decline of 26% from the year-ago number.

Ubisoft trades at a deep discount to its Vantage subsidiary's implied value after Tencent's €1.16B investment and industry restructuring. The restructuring targets a €1.25bn cost base, addressing fixed cost pressures and aligning expenses with current net bookings. Valuation scenarios suggest significant upside, with market mispricing evident versus both Vantage value and peer multiples (2x EV/EBITDA vs. 16.4x).

Key Takeaways NFG is expanding pipeline and storage assets to boost capacity, reliability and regulated earnings. Tioga Pathway and Shippingport Lateral are expected to add 395,000 Dth/day of capacity in late 2026. NFG plans $210-$250M in fiscal 2026 Pipeline & Storage spending to support rate base growth. National Fuel Gas (NFG - Free Report) is strengthening its pipeline network through pipeline and storage expansion projects and ongoing infrastructure modernization. These investments expand transportation capacity, enhance pipeline reliability and drive long-term regulated earnings growth.

National Fuel Gas is progressing with the Shippingport Lateral and Tioga Pathway expansion projects, both of which are expected to begin service in late 2026. Tioga Pathway is expected to provide 190,000 dekatherms per day (Dth/day) of capacity, while Shippingport Lateral is projected to add 205,000 Dth/day of transportation capacity. The company has launched the Line N System Upgrade Project, which will add 94,000 Dth/day of transportation capacity under a long-term contract with an investment-grade customer. The project replaces aging pipelines, improves system reliability and is expected to begin service in late 2028, supporting stable long-term cash flows.

National Fuel Gas aims to invest in the $210-$250 million range in Pipeline & Storage projects in fiscal 2026, supporting 5-7% long-term rate base growth and driving steady earnings expansion. NFG currently has 77 billion cubic feet (Bcf) of natural gas storage capacity and specializes in underground storage of natural gas.

According to the U.S. Energy Information Administration (“EIA”), nearly 44.9 bcf per day of new pipeline capacity is planned for 2026-2027. Favorable industry trends and NFG's disciplined capital investment plans are expected to support long-term Pipeline & Storage expansion and earnings growth.

Investments in Pipeline & Storage Boost Midstream OperationsAccording to the U.S. EIA, pipeline investments enhance transportation efficiency, reduce bottlenecks and improve energy delivery reliability. These investments also support rising oil and natural gas production, strengthen long-term fee-based cash flows and enhance connectivity among production regions, storage facilities and end markets.

Kinder Morgan (KMI - Free Report) is expanding its natural gas network through the Gulf Coast Express expansion, South System Expansion, Trident and Mississippi Crossing, increasing pipeline capacity, meeting rising power demand and supporting fee-based growth.

Energy Transfer LP (ET - Free Report) continues to expand its natural gas pipeline network through the Desert Southwest Pipeline, Hugh Brinson Pipeline and Mustang Draw projects, increasing transportation capacity and supporting EBITDA and cash flow growth.

NFG’s Earnings EstimatesThe Zacks Consensus Estimate for 2026 and 2027 earnings per share indicates an increase of 9.70% and 4.98%, respectively, year over year.

Image Source: Zacks Investment Research

NFG’s Returns on Equity (ROE)National Fuel Gas' trailing-12-month ROE is 20.62%, higher than the industry average of 10.94%.

Image Source: Zacks Investment Research

NFG’s Stock Price PerformanceIn the past month, the company’s shares have risen 4.2% against the industry’s 6.3% fall.

Image Source: Zacks Investment Research

NFG’s Zacks RankNFG currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
 

Jessica Inskip (@jessicainskip) takes us through today's Big 3. She highlights Mastercard (MA) as an opportunity within an AI gap she sees, Valero Energy (VLO) holding strong momentum into earnings season, and Bullish (BLSH) as a high-risk, high-beta trade pick.

, /PRNewswire/ -- Lennox (NYSE: LII), a leader in energy-efficient building and home comfort solutions, will report second quarter 2026 financial results before the market opens on Wednesday, July 29, 2026. An earnings conference call and webcast are scheduled for the same day at 8:30 a.m. Central Time. CEO Alok Maskara and CFO Michael Quenzer will provide a summary of the company's financial results and outlook, followed by a question-and-answer session.

To participate in the earnings conference call, please call 800-267-6316 (U.S.) or +1 203-518-9783 (international) at least 10 minutes prior to the scheduled start time and use conference ID LIIQ226. The conference call will also be webcast live at www.investor.lennox.com.

A replay of the conference call will be available until August 5, 2026, by calling toll-free 800-839-5484 (U.S.) or +1 402-220-1522 (international). The call also will be archived on the company's investor relations website.

About Lennox
Lennox (NYSE: LII) is a leader in energy-efficient building solutions and is committed to creating healthier and more comfortable environments. Serving residential and commercial customers, the company delivers innovative heating, cooling, indoor air quality, refrigeration, and water heating systems. Through trusted products, parts, and services, and advanced technology, Lennox delivers connected solutions that support the full lifecycle of customer needs. Additional information is available at www.lennox.com.

Media Contact
[email protected]

Investor Relations Contact
[email protected]

SOURCE Lennox International Inc.

WINCHESTER, Va.--(BUSINESS WIRE)--Trex Company, Inc. [NYSE: TREX], the world's largest manufacturer of wood-alternative composite decking and railing, and a leader in high-performance, low-maintenance outdoor living products, will issue its second quarter 2026 earnings release on Tuesday, August 4, 2026, at 6:30 AM ET. You are invited to participate in the Company's conference call hosted by senior management on Tuesday, August 4, 2026, at 8:00 AM ET. Their prepared remarks will be followed by.

Key Takeaways Marvell provides the backbone of the massive AI compute buildout. Big tech hyperscalers are moving more toward the custom silicon that MRVL builds. MRVL shares are retreating to the rising 10-week moving average - offering an attractive buy zone. What Does Marvell Do?Marvell Technology ((MRVL - Free Report) ) is a leading AI infrastructure company that powers the backend of AI data centers. To train AI models, thousands of GPUs are grouped together. Moving data between these GPUs is critical. Marvell provides the connectivity and optics solutions to ensure that massive amounts of data can fly through fiber optic cables at blistering speeds. Additionally, Marvell provides custom-designed chips for hyperscalers like Amazon ((AMZN - Free Report) ) and Alphabet ((GOOGL - Free Report) ). The custom-designed chips are tailored specifically to the big cloud provider’s data centers, helping them to save on power costs.

Marvell: An AI BeneficiaryAI has been the fastest and most predictable growth industry on Wall Street. Marvell is already delivering record earnings numbers, but Wall Street analysts see the growth only just beginning. Zacks Consensus Estimates suggest that MRVL will achieve top-and-bottom-line growth of 40% or more through 2028.

Image Source: Zacks Investment Research

The Next Trillion Dollar CompanyA few months ago, Marvell CEO Matt Murphy gave the keynote speech at the Computex tech trade show in Taipei. Prior to Murphy’s speech, NVIDIA’s ((NVDA - Free Report) ) iconic CEO explained why Marvell will be the next trillion-dollar company:

“When you take a computing problem, and you disaggregate it into a lot of parts, and you distribute across the data center, what’s necessary is connectivity. That’s the reason why Matt’s doing so well. That’s the reason Marvell is so essential. That’s why you’re going to be the next trillion-dollar company.”

Because Jensen Huang is CEO of the most important AI company and has visibility into the industry that no one else has, he’s worth listening to. Meanwhile, Marvell and NVIDIA recently expanded their relationship which should help to shorten adoption cycles, and broaden Marvell’s addressable opportunities across AI infrastructure builds.

MRVL Follow the Trend“The trend is your friend until the end when it bends.” ~ Ed Seykota

Marvell has been one of the best-performing stocks over the past year, gaining 163% versus the S&P 500’s 20%.

Image Source: Zacks Investment Research

One of the best ways for intermediate investors to gauge the trend is to follow the 10-week moving average. MRVL shares are retreating to the 10-week moving average for the first time since March. The first retreat to the 10-week moving average after a major breakout offers an extremely favorable reward-to-risk zone.

Image Source: TradingView

Bottom Line

While NVIDIA supplies the AI brains, Marvell builds the nervous system. Regardless of who wins the AI software or hardware wars, the entire AI ecosystem fundamentally requires Marvell’s specialized connectivity and custom architecture to function.

Microsoft has started replacing OpenAI and Anthropic models with its own AI systems in products including Excel and Outlook, marking a new step in the company’s push to reduce the cost of running AI across its software business, according to a Bloomberg report.

Tens of thousands of prompts in the spreadsheet and email apps are now being completed each week by Microsoft’s internally built MAI models, according to a person familiar with the work. The apps previously relied more heavily on models from OpenAI and Anthropic.

The shift remains small compared with Microsoft’s overall AI usage, but it shows the company is moving more of its AI workload onto systems it controls. That matters as Copilot expands across Microsoft 365 and drives higher demand for compute and model access.

Advertisement

Microsoft currently benefits from its long running OpenAI partnership, which gives it access to advanced models at favorable economics. But the company is preparing for a future where outside AI labs can charge more for their models, especially as enterprise demand grows.

Microsoft AI chief Mustafa Suleyman said in June that the company wanted to reduce spending on Anthropic by using more MAI models. “We pay a lot of money to Anthropic, so our goal is to reduce and ultimately eliminate that cost,” he said at the time.

The company announced seven new AI models at its Build developer conference in June, including one it says can match the coding abilities of Anthropic’s Opus 4.6 at lower cost. Microsoft’s MAI models are also available in GitHub Copilot, while a Microsoft built transcription model is expected to be used in Teams and other products in the coming months.

The move does not mean Microsoft is cutting off OpenAI or Anthropic. Instead, it points to a more mixed model strategy, where Microsoft uses outside systems for high end tasks while shifting cheaper or more routine workloads to its own models.

For Microsoft, the goal is simple: keep Copilot growing without letting model costs dictate the economics of the business.

Disclosure: This article was edited by Estefano Gomez. For more information on how we create and review content, see our Editorial Policy.

Key Takeaways UEC now has two U.S. ISR platforms operating at Christensen Ranch and Burke Hollow.New header houses and Burke Hollow's first full-quarter contribution are expected to lift output.UEC holds $794M in liquid assets and no debt, but costs and sales timing remain volatile. Uranium Energy Corp. (UEC - Free Report) is moving from uranium optionality toward operational execution. The company now has two U.S. in-situ recovery platforms operating, giving investors a clearer production base.

The setup is still uneven. Liquidity and project depth support the longer-term case, but results may remain choppy while wellfields, approvals and sales timing settle.

How UEC Built a Two-Hub ISR PlatformUEC’s current operating base is anchored by Christensen Ranch in Wyoming and Burke Hollow in South Texas. Christensen Ranch feeds the Irigaray Central Processing Plant, while Burke Hollow is tied to the Hobson Processing Facility.

That hub-and-spoke structure gives UEC licensed processing capacity across two regions. Irigaray is licensed for up to 4 million pounds of uranium annually, and Hobson is licensed to process as much as 4 million pounds per year.

Burke Hollow commenced production on April 8, 2026, after approval from the Texas Commission on Environmental Quality. Christensen Ranch has already produced 276,516 pounds since its August 2024 restart.

Why Uranium Energy Sees More Volume AheadThe near-term production story rests on Christensen Ranch header houses and Burke Hollow’s first full-quarter contribution. Three new header houses in Wellfield 11 began production late in the third quarter of fiscal 2026 after state approval.

One additional header house was complete and awaiting approval, and five more were under construction in Wellfields 12 and the 10-extension. These additions are expected to lift fourth-quarter production as more infrastructure operates.

The third quarter of fiscal 2026 did not yet capture that full benefit. Preconditioning, leaching and precipitation costs were recorded before the related production volume was fully reflected.

UEC Growth Pipeline Extends Beyond Current MinesLudeman, Sweetwater and Roughrider form the next layer of UEC’s growth pipeline. At Ludeman, UEC completed a 240-hole delineation drilling program, while engineering for a satellite ion-exchange plant progressed.

Sweetwater adds scale to the Wyoming opportunity. The project has been designated as a FAST-41 transparency project, and UEC reached a permitting milestone with the Bureau of Land Management’s completeness review of its Plan of Operations for in-situ recovery operations.

At Roughrider, more than 80% of the planned 35,000-meter conversion core drilling program has been completed to support a planned pre-feasibility study. For peer context, Cameco Corporation (CCJ - Free Report) gives investors exposure to a larger uranium fuel-cycle company. Centrus Energy Corp. (LEU - Free Report) is more closely tied to nuclear fuel and enrichment.

Where Uranium Energy Still Faces Execution RiskExecution risk remains the main near-term issue. In the third quarter of fiscal 2026, UEC produced 32,195 pounds at a total cost of $54.61 per pound and a cash cost of $46.69 per pound.

Total cost per pound rose 25% sequentially, driven by lower production from late approvals and higher state taxes. Production-based royalties, ad valorem and severance tax per pound increased to $8.11 from $6.67 in the second quarter of fiscal 2026.

Sales timing also adds volatility. UEC made no sales in the third quarter of fiscal 2026 as management preserved inventory under its 100% unhedged strategy, which can leave quarterly revenues uneven. 

The Zacks Consensus Estimate for UEC for fiscal 2026 is currently at a loss of 19 cents per share wider than the loss of 17 cents reported in fiscal 2025. The consensus for fiscal 2027 also suggests a loss of 11 cents per share as shown in the chart below.

Image Source: Zacks Investment Research

Shares of UEC have declined 27.8% in the past three months compared with the industry’s 6.7% fall.

Image Source: Zacks Investment Research

How UEC’s Ratings Fit This Uneven SetupThe bottom line is that UEC has a more tangible operating platform, but the investment case still depends on execution. Liquidity is a support, with $794 million of liquid assets at the end of the third quarter of fiscal 2026, including $488 million in cash and no debt.

UEC currently carries a Zacks Rank #4 (Sell). That rank points to near-term caution, as sales and costs remain sensitive to approvals, wellfield timing and market-driven sales decisions.

You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

The stock’s Zacks Style Scores also lean weak. UEC has a VGM Score of F, with a Value Score of F, Growth Score of F and Momentum Score of D. Since Style Scores complement the Zacks Rank, those marks do not strengthen the near-term setup.

For investors, the contrast is clear. UEC’s inventory, liquidity and project base support a constructive long-term narrative, but the current Rank and Style Scores argue for patience until production stabilizes and estimate trends improve.

This strategic partnership aims to enhance Kodiak’s energy infrastructure initiatives, providing scalable power generation solutions to meet increasing demand.

• Kodiak Gas Services shares are advancing steadily. Why is KGS stock trading higher?

Kodiak Gas Services entered a multi-year agreement with Baker Hughes, which includes an initial order for gas turbines and generators expected to deliver approximately one gigawatt of power capacity by 2030.

The initial order includes NovaLT16 and Frame 5 gas turbines, along with BRUSH generators, to support growing power demand from data centers and energy infrastructure.

The equipment will be deployed in key U.S. markets to provide flexible behind-the-meter power amid rising electricity demand and grid constraints.

This collaboration is designed to support the growing energy infrastructure needs, particularly for data centers, highlighting the importance of flexible and efficient power solutions.

KGS Technical Outlook: Key Levels and MomentumFrom a technical perspective, Kodiak Gas Services has shown a strong performance over the past year, with a notable 12-month gain of 109.58%. Currently, the stock is trading about 1.2% above its 20-day simple moving average (SMA) of $69.88 and 0.8% above its 50-day SMA of $70.16. The 200-day SMA, at $50.17, indicates a significant bullish trend, with the stock trading 41% above this level.

The Relative Strength Index (RSI) currently sits at 45.90, indicating a neutral momentum phase, suggesting that the stock is neither overbought nor oversold at this time. This level of RSI reflects a balanced market sentiment, while the moving averages indicate a potential bearish crossover with the 20-day SMA below the 50-day SMA.

Key Resistance: $77 — Nearby level where rebounds can stall. Key Support: $65 — Nearby level where buyers previously stepped in. KGS Earnings Preview And Analyst Price TargetsKodiak Gas Services is slated to provide its next financial update on Aug. 5 (estimated).

EPS Estimate: 75 cents (Up from 43 cents) Revenue Estimate: $385.56 million (Up from $322.84 million) Valuation: P/E of 89.5x (Indicates premium valuation) Analyst Consensus & Recent Actions: The stock carries a Buy rating with a consensus price target of $59.62. Recent analyst moves include:

Barclays: Overweight (Lowers target to $72 on July 8) Jefferies: Initiated with Buy (target $79 on June 4) Wells Fargo: Initiated with Overweight (Target $93 on May 27) How KGS Ranks On Momentum and ValuationBelow is the Benzinga Edge scorecard for Kodiak Gas Services, highlighting its strengths and weaknesses compared to the broader market:

Momentum: Bullish (Score: 94.96) — Stock is outperforming the broader market. Value: Weak (Score: 43.35) — Trading at a steep premium relative to peers. The Verdict: Kodiak Gas Services’ Benzinga Edge signal reveals a momentum-driven story, indicating strong performance in the market despite a weak value score. This suggests that while the stock is currently performing well, it may be trading at a premium compared to its peers.

KGS ETF Exposure and Passive Fund Flow Risk WisdomTree US SmallCap Dividend Fund (NYSE:DES): 1.03% Weight Significance: Because Kodiak Gas Services carries significant weight in this fund, any significant inflows or outflows will likely force automatic buying or selling of the stock.

KGS Stock Trades on WednesdayKGS Stock Price Activity: Kodiak Gas Services shares were up 1.47% at $68.01 at publication on Wednesday, according to Benzinga Pro data.

Photo via Shutterstock 

This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

To add Benzinga News as your preferred source on Google, click here.

Key Takeaways Datadog topped $1 billion in quarterly revenues as first-quarter 2026 sales rose 32% year over year.DDOG unveiled 100 plus AI and security capabilities and acquired Adaptive ML to expand AI agents.Datadog forecasts 2026 revenues of $4.30-$4.34B despite margin, competition and macro risks. Datadog (DDOG - Free Report) shares have surged 88.7% year to date, comfortably outpacing the Zacks Computer and Technology sector's 14.8% growth and the Zacks Internet Software industry's 8% decline over the same stretch of trading.

The rally reflects growing investor confidence in Datadog's role as a core observability and security platform for enterprises navigating increasingly complex, AI-driven infrastructure. With first-quarter 2026 results confirming accelerating growth and management issuing upbeat forward guidance, the near-term setup still looks favorable for investors willing to ride out some volatility, even as rising costs and intensifying competition warrant a genuinely watchful eye.

DDOG Outperforms Sector, Peers YTD
Image Source: Zacks Investment Research

Catalysts Fuelling DDOG’s RallyDatadog's first-quarter 2026 results showed revenues climbing 32% year over year to $1,006 million, marking the company's first quarter above $1 billion and a sequential acceleration from 29% growth in the prior period. Customers with annual recurring revenues of $100,000 or more grew 21% year over year to about 4,550. Non-GAAP operating margin held at 22%, while free cash flow reached $289 million.

Momentum has continued into the current quarter. Last month, Datadog hosted its DASH 2026 conference, unveiling more than 100 new capabilities to help customers manage growing AI and security complexity, including expanded agentic tooling. On June 30, the company announced its acquisition of Adaptive ML, a startup building a Reinforcement Learning Operations platform, which will join Datadog AI Research to accelerate work on specialized AI agents trained on real-world observability signals. The company also achieved FedRAMP High certification during the quarter and launched GPU Monitoring to help customers better manage AI infrastructure spend.

Forward-Looking Guidance by DDOG Holds PromiseFor the second quarter of 2026, Datadog guided revenues between $1.07 billion and $1.08 billion, non-GAAP operating income to be $225-$235 million, and non-GAAP earnings per share between 57 cents and 59 cents.

The Zacks Consensus Estimate calls for 2026 revenues of $4.34 billion, up 26.62% year over year, with earnings pegged at $2.41 per share, up 17.56%, suggesting the current valuation gap is arguably well justified by Datadog's faster, AI-driven observability growth trajectory relative to the broader field.

For full-year 2026, management projected revenues between $4.30 billion and $4.34 billion, non-GAAP operating income to be $940-$980 million, and non-GAAP earnings per share between $2.36 and $2.44, underscoring continued confidence in sustained double-digit growth.

Headwinds Worth MonitoringDespite the strong trajectory, risks remain. GAAP operating margin was just 1% in the quarter, reflecting heavy stock-based compensation and continued R&D investment, including newly absorbed costs tied to the Adaptive ML deal. Continued reliance on large enterprise deals also introduces some lumpiness to quarterly bookings, and management has flagged macro uncertainty tied to trade policy and IT spending as ongoing watch items.

Valuation and Competitive LandscapeDatadog carries a Zacks Value Score of F, trading at a forward 12-month price-to-sales ratio of 19.2X, well above the industry median of 4.78X. That steep premium reflects Datadog's notably stronger growth profile relative to slower-growing peers, whose more modest multiples mirror decelerating or largely flat expansion.

DDOG’s P/S Valuation
Image Source: Zacks Investment Research

DDOG faces significant competition from the likes of International Business Machines (IBM - Free Report) , Cisco Systems (CSCO - Free Report) and Dynatrace Software (DT - Free Report) , among others. Cisco Systems has advanced 45.2%, while Dynatrace has gained 4.1% and International Business Machines has returned 3.4%, highlighting Datadog's clear outperformance against all three legacy and pure-play rivals alike.

Cisco Systems leans on its deep network-layer footprint and hardware relationships to push observability bundles into existing accounts, while Dynatrace differentiates through AI-driven causal analytics aimed squarely at large enterprise customers. International Business Machines folds observability into its broader hybrid-cloud and consulting stack, giving it reach but comparatively less focus. Datadog's unified platform keeps winning share, though Cisco Systems, Dynatrace, and International Business Machines each retain entrenched enterprise relationships that keep the observability and security market intensely contested heading into the second half of 2026.

ConclusionWith accelerating revenue growth, robust guidance and steady AI-driven innovation spanning GPU monitoring, agentic security tooling and the Adaptive ML acquisition, Datadog's growth story remains firmly intact. Despite thin GAAP margins and a crowded competitive field, the near-term outlook still tilts favorably enough for patient, growth-oriented investors to consider Datadog.

DDOG currently carries a Zacks Rank #2 (Buy) and a Growth Score of A, a favorable combination that offers a strong investment opportunity per the Zacks proprietary methodology. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.